Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Versier

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Advances|May 15, 2026
Universal strategy to generate lentiviral vectors encoding lethal proteinsBenjamin Versier, Aravindhan Soundiramourty, Enzo Manchon, et al.
Frontiers in Immunology|March 23, 2026
Tunable CAR-NK-92 activity in the tumor microenvironment via a dual ATF4-responsive circuitEnzo Manchon, Nell Hirt, Aravindhan Soundiramourty, et al.
Cellular & Molecular Immunology|May 7, 2025
Harnessing nutrient scarcity for enhanced CAR-T-cell potency and safety in solid tumorsEnzo Manchon, Nell Hirt, Benjamin Versier, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Advances|May 15, 2026
Universal strategy to generate lentiviral vectors encoding lethal proteinsBenjamin Versier, Aravindhan Soundiramourty, Enzo Manchon, et al.
Frontiers in Immunology|March 23, 2026
Tunable CAR-NK-92 activity in the tumor microenvironment via a dual ATF4-responsive circuitEnzo Manchon, Nell Hirt, Aravindhan Soundiramourty, et al.
Cellular & Molecular Immunology|May 7, 2025
Harnessing nutrient scarcity for enhanced CAR-T-cell potency and safety in solid tumorsEnzo Manchon, Nell Hirt, Benjamin Versier, et al.
Pageof 1